Boise State University

ScholarWorks
Computer Science Faculty Publications and
Presentations

Department of Computer Science

3-2-2022

VigilRx: A Scalable and Interoperable Prescription Management
System Using Blockchain
Alixandra Taylor
North Idaho College

Austin Kugler
University of Idaho

Praneeth Babu Marella
George Mason University

Gaby G. Dagher
Boise State University

Publication Information
Taylor, Alixandra; Kugler, Austin; Marella, Praneeth Babu; and Dagher, Gaby G. (2022). "VigilRx: A Scalable
and Interoperable Prescription Management System Using Blockchain". IEEE Access, 10, 25973-25986.
https://doi.org/10.1109/ACCESS.2022.3156015

Received January 12, 2022, accepted February 20, 2022, date of publication March 2, 2022, date of current version March 11, 2022.
Digital Object Identifier 10.1109/ACCESS.2022.3156015

VigilRx: A Scalable and Interoperable Prescription
Management System Using Blockchain
ALIXANDRA TAYLOR1 , AUSTIN KUGLER
AND GABY G. DAGHER 4

2,

PRANEETH BABU MARELLA3 ,

1 North

Idaho College, Coeur d’Alene, ID 83814, USA
of Idaho, Moscow, ID 83844, USA
3 George Mason University, Fairfax, VA 22030, USA
4 Boise State University, Boise, ID 83725, USA
2 University

Corresponding author: Gaby G. Dagher (gabydagher@boisestate.edu)
This work was supported by the National Science Foundation Computer and Information Science and Engineering (CISE)
REU Program under Grant 2051127.

ABSTRACT Achieving interoperability between healthcare providers is a major challenge. Current systems
for managing prescription records suffer from data siloing, unnecessary record duplication, and slow record
transfers. In many systems, patients do not retain control over their prescription data. Instead, they must
use an intermediary to access or transfer their records. Furthermore, record transfers suffer from differing
standards between providers, outdated communication methods, and information blocking. Solving these
problems necessitates the creation of an interoperable prescription management system. Realizing such a
system requires considering security, efficiency, scalability, and other challenges. Recent regulatory actions
attempt to address these challenges, but fundamental issues persist. This paper proposes a patient-centric and
interoperable prescription system that ensures patient control, prevents information blocking, and improves
transfer efficiency. We call our solution VigilRx—a system that uses blockchain and smart contracts to
manage prescriptions. Stakeholders exist as one of three role-based smart contracts within the system: patient,
prescriber, or pharmacy. These role contracts ensure the system is patient-centric by assigning ownership of
prescription records directly to patients. Our smart contracts also ensure the system’s interoperability, as we
use a standardized prescription contract to ensure records can be easily managed. VigilRx’s use of blockchain
also promotes transparency by providing patients an explicit list of parties that hold permission to access their
records. Use of existing software patterns allows the system to adapt as needed. We implement VigilRx and
show that it is both scalable and efficient.
INDEX TERMS Blockchain, electronic health records, Ethereum, healthcare, prescriptions, smart contracts.

I. INTRODUCTION

Managing the transfer and control of healthcare records
among prescribers, pharmacists, and patients presents ongoing concerns within the U.S. healthcare system. Healthcare records often become fractured between various care
providers resulting in siloed, duplicated, or inconsistent information [10]. This partly results from the inefficient communication channels providers currently use [9]. Patients rarely
have direct control over their records and must rely on care
providers to transfer records on their behalf. Simply starting
these transfers can be excessively slow with most facilities
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taking 5-10 days just to initiate a transfer [29]. The transfer
process itself often requires a third-party health information
service provider (HISP) who may participate in information
blocking practices. Additionally, the sending and receiving
parties may not share a common HISP or other compatible transfer system. In these cases, antiquated technologies
such as fax machines or physical mail become necessary
intermediaries that add to the delay. Even in cases where
record transfer through a HISP is possible, differing storage
standards and data formats may necessitate further translation
before the data is useful within the receiving party’s system.
The realizing of an interoperable electronic health
record (EHR) solution faces regulatory and security hurdles
as well. The sensitive nature of patient EHRs makes them
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a valuable target for theft. Providers must facilitate the secure
transfer and storage of healthcare records while also complying with shifting regulatory standards. The time sensitive nature of EHR transfers requires that system designers
accommodate both efficiency and security. The need for efficient exchange is challenging for small providers who must
pay for access to expensive HISP platforms [23]. Challenges
regarding security and efficiency become especially relevant
in the transfer of prescription records. Untimely or inaccurate
transmission of sensitive data inhibits stakeholder access and
obstructs informed decision making.
Current solutions meant to address these challenges rely
on the exchange of prescription records between large HISP
companies. These companies have a vested interest in protecting their market share which often leads them to engage in
information blocking practices [8], [31]. Information blocking consolidates control for the blocking party and forces the
use of antiquated technologies. Information blocking challenges the legally recognized idea that patients should be in
control of their own health records (in the U.S., under the
Health Insurance Portability and Accountability Act [26]).
This paper proposes the use of blockchain technology as a
method for ensuring patient control over their records.
The overhead costs of record transfers between healthcare
providers is substantial. As of 2017, 61% of hospitals used
more than one method for receiving electronic healthcare
records with 33% using at least four [22]. The 21st Century Cures Act prompted the U.S. Department of Health
and Human Services (HHS) to address these issues through
regulatory reforms [24]. However, even under these reforms
patients still do not have direct control over their records.
These regulations only attempt to simplify record transfers
and do not directly ensure patient control over their personal
data. VigilRx’s design addresses the concerns raised by existing HISP-centered infrastructure and restores record control
to the patient using blockchain technology.
Other systems, such as MedRec [4], propose blockchainbased alternatives to the HISP-centered model of EHR management. Unlike our solution, MedRec focuses on an EHR
solution at large while our system addresses the unique
challenges of dealing with prescriptions specifically. The
presence of a global registrar entity in the VigilRx system
adapts ideas originally presented by MedRec. The Ancile [3]
system proposes the use of encryption techniques to ensure
secure data transfer and allow the storage of small health
records on the blockchain, like VigilRx. A later system,
called OpTrak [2], focuses on prescriptions but does not
explore alternatives to HISP control of patient data. OpTrak
uses blockchain as an access control mechanism to establish communication between siloed databases. Our system
advocates for allowing patients to own and distribute access
to their prescription records directly. More recently, SecureRx [1] proposes integration between a blockchain-based
prescription solution and the existing federal opioid database
RxCheck. This use of existing databases is unlike VigilRx.
Our system does not rely on existing tracking systems but can
25974

still operate alongside them. In addition, a stakeholder within
the SecureRx system interacts with a SecureRx server instead
of the blockchain directly. VigilRx provides stakeholders with
direct access to the blockchain and relevant data, decreasing
the reliance on additional infrastructure.
VigilRx is a prescription management system that facilitates interoperability among stakeholders while remaining patient-centric. The system (1) provides patients direct
authority over who can access their prescription data,
(2) prevents information blocking by ensuring patients can
perform actions related to their data without reliance on an
intermediary, and (3) ensures prescription data can be efficiently transferred among relevant stakeholders.
To accomplish these three goals, VigilRx uses blockchain
and smart contracts. Smart contracts define and enforce the
actions stakeholders may take within the system. They allow
prescribers to originate prescriptions but automatically transfer ownership to patients. Interactions are ultimately under
patient control with patients deciding on a case-by-case basis
how to distribute access to their data. Patient control becomes
the default under our system, replacing abstraction through
third party services.
The role of blockchain as a public and distributed ledger
enables patient access to prescription records. We accomplish
on-chain storage of prescription data using national drug
codes (NDC). These codes are drug identification numbers
already managed by the U.S. Food and Drug Administration [21]. This approach allows VigilRx to maximize accessibility and minimize transaction costs without compromising
blockchain’s value as a tool for access control. VigilRx also
makes use of software patterns that allow for its implementation to evolve. Software patterns like abstract factory and
flyweight provide a mechanism for future implementations
of the system without compromising the utility of existing
VigilRx data on the blockchain.
VigilRx proposes a patient-centric and interoperable prescription tracking solution. Our system combats information blocking by offering an alternative to traditional
HISP-centered models of prescription data transfer. Originating prescriptions with the prescriber and automatically
transferring ownership to the patient allows the flow of data
to begin with the most affected stakeholders. Patients gain
power over their data by consenting to its distribution on a
case-by-case basis and have a clear record of permissioned
parties. Our system may provide the most utility to small,
rural, and critical access care providers with limited resources
by removing the cost of unnecessary intermediaries that disproportionately affects these providers.
A. CONTRIBUTIONS

The contributions of this paper are as follows:
1) We introduce VigilRx, a blockchain-based prescription
management system that aims to replace existing HISP
architecture and prevent information blocking. VigilRx
utilizes roles to determine which actions stakeholders
may perform with a specific emphasis placed on patient
VOLUME 10, 2022
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2)

3)

4)

5)

6)

control. Patients actively participate in the management
of their prescription data. As a result, VigilRx achieves
a patient-centric design that is interoperable, scalable,
and efficient.
VigilRx achieves this patient-centric design by building
a record of stakeholder access within the system and
requiring active patient consent for actions related to
their prescriptions. Patients are given constant access
to a clear record of permissioned stakeholders with
access to their data. Furthermore, patients must provide consent during relevant stages of their prescription
management. Our system actively verifies the role of all
parties in order to protect users and ensure that only the
appropriate parties may access or alter records.
VigilRx achieves a patient-centric design by allowing
patient consent to actions related to their prescriptions.
Patients have constant access to a record of parties
they have previously provided consent to. We verify the
role of all parties during this consent process to ensure
only those with patient permission may access records.
A global registrar contract ensures the integrity of this
verification by authenticating the role of each relevant
stakeholder.
The free and efficient exchange of data between stakeholders is a vital part of our system. We achieve
this interoperability by enabling the exchange of data
without the requirement for translation between formats. Our system avoids data duplication between
silos and accomplishes the exchange of prescription
records without unnecessary overhead common in
HISP-oriented systems. Therefore, patient data is current and readily accessible to stakeholders unlike in
passive and siloed HISP systems.
To enable features not normally available in a
blockchain-based system, we apply software patterns.
Our system utilizes three software patterns to achieve
adaptability (abstract factory pattern), efficiency (pubsub pattern), and scalability (flyweight pattern) [7].
Abstract factory allows the creation of new role contract implementations in our system; pub-sub allows
notification of changes in the status of patient prescriptions; flyweight enhances scalability by avoiding
unnecessary data duplication.
We implemented VigilRx using Ethereum smart
contracts. Our experimental testing results show that
VigilRx is scalable with respect to the number of
stakeholders. The results also show that VigilRx is
efficient with most actions in the system being relatively low-cost once prescriptions have been initialized.
As seen in our efficiency evaluation (see section VI-E),
most actions remain under an average cost
of 90,000 Ethereum gas.

II. RELATED WORK

A few research papers: Ekblaw et al. [4], Dagher et al. [3],
Zhang et al. [2], and Alnafrani and Acharya [1] explore
VOLUME 10, 2022

blockchain’s use in healthcare, specifically regarding
electronic health records (EHRs). Some of these articles
focus on using blockchain as an access control method for
external health record databases. Others utilize blockchain as
a transparent logging mechanism to record actions related to
personal health records.
Ekblaw et al. [4] created MedRec, a patient-centric modular architecture for managing EHRs. MedRec focused
on providing faster access to health records, improving
interoperability, increasing patient control, and providing
data to researchers. VigilRx also focuses on increasing
patient control and interoperability. However, we specifically
address challenges unique to prescription records. MedRec
used blockchain as an access control method to external
databases without storing any medical records directly on
the blockchain [4]. VigilRx differs in that it does not utilize off-chain data storage. MedRec is also notable for its
use of anonymized healthcare data as a mining reward for
its blockchain. In MedRec, a notification system informs
patients on the usage of their data [4]. VigilRx ensures patient
consent similarly to MedRec’s notification system, although
we add multi-signature confirmations to the process.
Dagher et al. [3] designed the Ancile system which used
blockchain technology for access control. Ancile specifically
focused on patient-centric control, security, and data sharing.
In their system, on-chain data references are used to query
established off-chain databases. Similarly, it is possible to
implement VigilRx alongside existing databases. The Ancile
system used Ethereum smart contracts and cryptographic
methods to accomplish its goals. Notably, Ancile used proxy
re-encryption to facilitate the secure transfer of records [3].
Ancile also proposed the storage of small, encrypted records
directly on the blockchain to speed up record transfers [3].
In VigilRx, we use existing standards to allow the on-chain
storage of small prescription records in a similar manner.
Another unique aspect of Ancile is its use of a consensus
algorithm based on JP Morgan’s Quorum [3]. VigilRx differs
in its goal of being blockchain agnostic, where it can exist
on any smart-contract enabled blockchain without requiring
a specific consensus algorithm.
Zhang et al. [2] proposed a system called OpTrak that
focused heavily on using blockchain to address the U.S.
opioid crisis. The system’s goals were the prevention of data
hoarding, doctor shopping, and over-prescription. OpTrak
uses the Ethereum blockchain as an access control mechanism for referencing existing prescription databases. OpTrak
aimed to quickly inform providers of important events, such
as the filling of an opioid prescription [2]. VigilRx differs
from OpTrak as we focus on building a prescription management system that allows for direct control of records
instead of simply tracking stakeholder access. Furthermore,
VigilRx does not limit its focus to opioids, instead focusing
on prescription records in general.
Alnafrani and Acharya [1] developed the SecureRx framework to facilitate interstate cooperation between existing
Prescription Drug Monitoring Program (PDMP) databases.
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A. Taylor et al.: VigilRx: Scalable and Interoperable Prescription Management System Using Blockchain

SecureRx particularly specified integration with the existing RxCheck PDMP database. Their system focused on
prescription tracking and not management. In the system,
SecureRx delivers patient prescription information to PDMPs
for tracking purposes [1]. SecureRx’s focus on prescriptions
is like VigilRx but different in its intended use as a prescription tracker and reliance on RxCheck. SecureRx used
Ethereum smart contracts and a web application, like our
VigilRx system.
Other related works focused the use of smart contracts
for prescription management, such as Garcia et al.’s [5]
research on low-cost smart contract prescription systems.
Thatcher and Acharya developed and tested a prescription
system called RxBlock that featured user and prescription
smart contracts [6]. Work by Gropper [14] researched the
issue of identity management in the context of blockchain
EHRs and proposed a method of associating patient identities
with a blockchain identifier. Further work by Zhang et al. [16]
applied the emerging HL7’s Fast Healthcare Interoperability
Resources (FHIR) standard in a blockchain-based EHR system called FHIRChain. Benita et al. [15] proposed a system
that used Ethereum and a mobile app for prescription drug
tracking and authentication. Zhang et al. [7] also developed
a system called DASH that served to identify use cases for
blockchain in healthcare and evaluated design considerations
for its effective application.

III. BACKGROUND
A. HIPAA AND HITECH

Systems developed for use within the U.S. healthcare industry
must comply with relevant laws. These include the Health
Insurance Portability and Accountability Act (HIPAA) of
1996 and the more recent Health Information Technology
for Economic and Clinical Health (HITECH) Act of 2009.
Title II of HIPAA seeks to establish legal standards for the
use of EHRs, create national provider identifiers (NPIs) [20],
and promote widespread EHR use. Due to its strong focus on
EHRs, Title II is most relevant to digital systems dealing with
healthcare records.
Title II includes three distinct parts labeled 45 CFR Parts
160, 162, and 164. Parts 160 and 164 are especially relevant
to blockchain-based prescription solutions. Part 160 defines
relevant terms and establishes the obligations of involved
parties. The section defines covered parties as organizations
with a role in the transfer of electronic protected health
information (e-PHI). Any organization considered a covered
party must comply with the guidelines of HIPAA. VigilRx
fits into this category due to its handling of e-PHI.
Part 164 includes two sections vital to HIPAA compliance:
the Privacy Rule [32] and the Security Rule [33].
The Privacy Rule is central to HIPAA, given its stated
purpose to ‘‘define and limit the circumstances in which
an individual’s protected health information may be used or
disclosed by covered entities.’’ The Privacy Rule also defines
protected health information: ‘‘all individually identifiable
25976

health information held or transmitted by a covered entity or
business associate, in any form or media, whether electronic,
paper, or oral’’ [32]. This definition includes any data pertaining to the:
• Individual’s past, present, or future physical or mental
health
• Provision of healthcare to the individual
• Past, present, or future payment for the provision of
healthcare to the individual
The Privacy Rule goes on to enumerate the circumstances
under which the usage or disclosure of protected health
information is acceptable. Covered entities must disclose
PHI when a patient requests it, or when the U.S. Department of Health and Human Services (HHS) is undertaking
a compliance investigation, review, or enforcement action.
Covered entities may use and disclose PHI without authorization in some cases. For example, covered entities can
use PHI for their ‘‘own treatment, payment, and health care
operations’’ [32]. VigilRx enhances transparency in regards
to this provision because patients can view a list of entities
that have permission to use their data.
Protecting patient prescription data is another major concern of HIPAA as defined within the Security Rule. The Security Rule can be understood in terms of its general rules [33],
the first being to ‘‘ensure confidentiality, integrity, and
availability of all electronic protected health information the
covered entity or business associate creates, receives, maintains, or transmits.’’ Additionally, confidentiality requires that
e-PHI is not made available to unauthorized persons and its
integrity is preserved. The preservation of integrity requires
e-PHI ‘‘is not altered or destroyed in an unauthorized manner’’ [33]. VigilRx stores small prescription records directly
on the blockchain which inherently protects its integrity. The
blockchain itself is effectively immutable and therefore a
record of data alterations is available.
Under the Security Rule, ‘‘availability’’ means all e-PHI
must be accessible to any authorized person who demands
it. The use of blockchain serves this requirement well by
providing patients ready access to their data and taking away
the cumbersome requirements of shuffling records between
the different databases. Whether through a mobile app, home
computer system, or other device, the patient simply needs
a blockchain address in order to access their prescription
information.
The provisions of HIPAA were further expanded in 2009
with the addition of the HITECH Act, focusing on making electronic copies of patient health records available to
patients on request and tightening the maximum allowable
time period for the delivery of such information. HITECH
also strengthened requirements that providers keep disclosures of PHI ‘‘to the minimum necessary to accomplish the
intended purpose of such use, disclosure, or request. . . ’’ [28].
This is another area in which blockchain naturally
excels, allowing rapid record retrieval from the chain and
providing patients with logs showing who can access
their e-PHI.
VOLUME 10, 2022
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B. INFORMATION BLOCKING

Healthcare information blocking occurs when persons or
entities knowingly and unreasonably interfere with the
exchange or use of electronic health information [31].
According to the Office of the National Coordinator for
Health Information Technology (ONC), an information
blocking incident must meet three criteria:
•

•
•

Interference. Information blocking requires some act
that interferes with the ability of authorized persons or
entities to access, exchange, or use electronic health
information. This can result from explicit policies prohibiting the sharing of information, or from more subtle
business, technical, or organizational practices that add
to the cost or difficulty.
Knowledge. The decision to engage in information
blocking must be knowingly made.
No reasonable justification. Not all conduct that
knowingly interferes with electronic health information
exchange is information blocking. Concerns related to
privacy, security, and patient safety can be interpreted
as valid reasons for engaging in information blocking
practices.

Examples of information blocking practices include contract terms that restrict access to EHR, charging prohibitive
transfer fees, and implementing systems in ways that substantially increases the cost. As far back as 2015, ONC identified the prevalence of these practices and several of their
side effects [31]. Information blocking slows EHR transfers,
increases their cost, and fractures data between competing
entities. As of 2021, information blocking practices continue
to be an issue. Of surveyed health information exchange
organizations, 55% experienced information blocking from
EHR vendors and 30% experienced information blocking
from healthcare providers [8].
The most commonly observed information blocking methods were HISPs charging unreasonably high transfer fees and
large healthcare providers refusing to share patient records.
These common information blocking methods suggest that
EHR vendors and HISPs are using the premise of privacy,
security, and safety to obscure a conflict of interest that
benefits them financially while also preventing realization of
the legal and ethical requirements of HIPAA.
C. BLOCKCHAIN

Satoshi Nakamoto originally proposed the concept of
blockchain in the 2008 Bitcoin whitepaper [13]. Blockchain
is a method of storing data in a distributed manner using a
network of computers without reliance on a central authority.
Groups of data exist as blocks that are ‘‘chained’’ together
in chronological order from oldest to newest using a cryptographic method called hashing. Participants in a blockchain
system store these blocks on their personal computers and
communicate with each other to ensure they remain the same
across the network. An individual’s data is considered invalid
if it is inconsistent with the majority of other participants.
VOLUME 10, 2022

One goal of blockchain is immutability, meaning data
cannot change after it is stored. This property exists so long
as most participants do not act maliciously. As a result,
blockchain is extremely secure because any attacker must
control the majority of participants before they can modify
the blockchain-stored data. For the purposes of blockchain,
the importance of participants is determined by the amount
of computational power they can contribute to the network.
D. ETHEREUM AND SMART CONTRACTS

Ethereum is a specific implementation of blockchain created
by Vitalik Buterin in 2013 [12]. Like all blockchain implementations, it collects groups of transactions within the network into blocks and uses cryptographic hashes of previous
blocks to secure the immutability of the chain’s contents.
Ethereum accomplishes block selection using a proof-ofwork algorithm like that proposed in the Bitcoin whitepaper [13]. Ethereum is notable as it allows the inclusion of
smart contracts, whose implementation can structure the flow,
behavior, and accessibility of on-chain data.
Smart contracts are software programs stored on a
blockchain. Programmers can use smart contracts to create decentralized applications (dapps) that expand the
blockchain’s functionality. For example, smart contracts can
serve as an abstract representation for system users, providing them with relevant functionality. The use of smart
contracts requires the paying of a fee, measured in an
Ethereum-specific unit called gas. The most popular programming language for Ethereum smart contracts is called
Solidity.
E. Web3 INTERFACE

Web3 is a software library that allows programmers to connect traditional applications with smart contracts or other
decentralized systems. Currently, the Web3 library is available for use in several popular programming languages,
including JavaScript, Java, Python, and Go. The system
proposed in VigilRx utilizes the Python distribution of this
library, known as Web3.py.
F. GANACHE BLOCKCHAIN

Ganache [18] is a blockchain intended for developing and
testing decentralized applications locally without having to
interact with outside peers. Ganache allows developers to test
smart contracts intended for deployment on the live Ethereum
blockchain. Ganache’s testing environment is configurable,
allowing multiple tests to execute using the same settings.
G. SOFTWARE PATTERNS

Software patterns are general, reusable solutions to commonly occurring problems in software design. Software
patterns are not typically represented by source code or
libraries but rather as a template that addresses a given challenge. Our system discusses the application of three such
templates.
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1) ABSTRACT FACTORY

Abstract factory [7] is a pattern that builds on the concept of
a ‘‘concrete factory’’ and increases its flexibility. A concrete
factory is any software object that creates another object of
a specific and static type. An abstract factory encapsulates
a group of these individual factories who share a common
theme. The goal of this pattern is to separate the details of an
object’s implementation from its general use as a member of
a common class.
2) FLYWEIGHT

Flyweight [7] is a pattern dealing with data composed of simple, repeatable elements. The goal of flyweight implementation is to minimize memory usage by maintaining a consistent
access structure between data objects. Flyweight works by
storing commonly accessed data and providing references
to its storage locations. This allows objects to access the
data through references without storing it themselves. Thus,
avoiding unnecessary data duplication.
3) PUBLISHER-SUBSCRIBER

Publisher-Subscriber (pub-sub) [7] is a pattern that applies to
the sending and receiving of messages. In the context of smart
contracts, a pub-sub pattern is useful for monitoring changes
in the status of an on-chain contract. For example, if a patient
needs a fill or a refill of their prescription they can simply
change a state variable within their smart contract (via a web
app). Subscribed care providers, such as the prescription’s
issuer or a filling pharmacy, can actively monitor these state
variables for changes. When such a change occurs the care
provider can then delegate any necessary actions off-chain
without accruing additional cost or processing strain on the
blockchain itself.
IV. SOLUTION: VigilRx
A. OVERVIEW

VigilRx is an interoperable and patient-centric prescription
management system where record management is accomplished through blockchain technology. Our system uses
smart contracts to allow all actions necessary within a usable
prescription system. Our system is role-based with a user’s
role defining the actions they may take within the system.
We represent these roles using the following smart contracts: the global registry contract for an administrator; prescription contract for medications; patient role contract for
patients; prescriber role contract for prescribers; and pharmacy role contract for pharmacists. This model of contracts
allows the creation of new role contract instances, prescribing, filling of prescriptions, requesting of refills, and permissioning required to initiate these processes. We make
these actions accessible to non-technical stakeholders using
a modern web application.
B. SOFTWARE COMPONENTS

The VigilRx system consists of two main software
components: a web application and a decentralized
25978

application (dapp) running on smart contracts. A library
known as Web3 serves as the bridge between these two
components. We use an encryption scheme to ensure all
HIPAA-protected information is secure.
The web application serves as a non-technical access point
for the blockchain-based dapp. Every stakeholder creates an
account via the web app through a process that requires specifying their respective role, providing relevant information on
themselves for validation, and then associates the user with a
smart contract on the blockchain. A public-private key pair
assigns ownership of this role contract to the stakeholder.
The public key identifies the stakeholder, and the private key
allows the signing of contract actions. This scheme serves to
verify the keyholder’s identity through asymmetric cryptography. The structure of the role contracts further determines
what actions are available through the web app.
The VigilRx dapp runs on smart contracts written in the
Solidity programming language. New role contracts originate
with a global registry contract (GRC) which uses the abstract
factory pattern to create a role contract of the appropriate type
for the given user.
The behavior of these role contracts follows their respective code implementation but also inherits from one of four
standardized interfaces: patient, prescriber, pharmacy, or prescription. These interfaces allow for querying data within the
system via the flyweight pattern and offer standard functions
for all basic inter-contract actions.
The Web3 library serves as a bridge between these two
components. Use of this library allows data to be fetched
from the blockchain and displayed on the web app without
requiring users to interact with the chain directly. Web3
also allows the web app back-end to take advantage of the
pub-sub pattern and regularly check specific contracts for
status changes. The front-end can then notify the user to act
if needed. For example, the front-end will notify a prescriber
of a refill request.
C. SYSTEM SMART CONTRACTS

VigilRx proposes six smart contract designs: the global registry contract, concrete factory contract, prescription contract,
patient role contract, prescriber role contract, and pharmacy
role contract. Figure 1 shows a UML diagram of the relationships between the principle smart contracts.
1) GLOBAL REGISTRY CONTRACT

The global registry contract (GRC) is responsible for user
registration, validating user roles, and ensuring the creation
of role contracts. User registration occurs through the transmitting of user data using the existing Transport Layer Security (TLS) protocol. System administrators validate this data
and authorize the creation of the appropriate role contract.
The GRC uses the abstract factory pattern and a mapping
of concrete factory contracts (CFC) to initiate this creation
process and commits a new role contract to the blockchain.
The user the receives the role contract address from the GRC.
VOLUME 10, 2022
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like these can exist on top of the VigilRx system without
compromising the usefulness of existing contracts.
3) PRESCRIPTION CONTRACT

FIGURE 1. VigilRx role and prescription smart contracts.

The GRC is also the entry point for new types of concrete
factory contracts. When the addition of a new CFC type is
necessary, the owner of the GRC (effectively a system administrator) can verify the factory’s address and add it to the
GRC’s mapping. This new address can override or augment
existing CFC implementations for entirely new functionality.
Lastly, the GRC tracks the contract addresses of all role
contracts and their classifications. This allows contracts
within the system to verify the status of a contract address
with the GRC before allowing certain actions. For example,
if a patient is permissioning a new address, the patient’s role
contract can check the provided address against the GRC
to ensure it belongs to a valid provider within the VigilRx
system.

Prescription contracts represent patient prescriptions within
the VigilRx system. All prescriptions include the contract
address of the prescriber, the contract address of the owner
(the patient), and a list of permissioned contracts (e.g. filling
pharmacies). Also included is the national drug code of the
medication prescribed, the quantity of the medication, and
the number of refills remaining. Each prescription contract
includes two special flags that allow the pub-sub pattern to
indicate when a prescription is ready for filling or refilling.
Permissioning, filling, and refilling are handled inside the
prescription contract. It provides functions that are callable
by other role contracts within the system. Outside of the prescription contract, role contracts call a prescription contract
function to check the sending address against the contract
owner, prescriber, or permissions list as appropriate. The
information in the contract is only altered if the request is
made in the proper way by an authorized party. Flags indicating a fill or refill request can also be set at this point.
4) PATIENT ROLE CONTRACT

Patient contracts represent unique patients in the VigilRx system. They include a list of the patient’s prescription contract
addresses and a mapping of prescriber contract addresses
authorized to write prescriptions for the patient. Every patient
contract has functionality for adding and removing permissioned prescribers, as well as adding and removing permissions from owned prescriptions. Additionally, the patient
contract has a method for initiating a fill request by triggering
a flag change on any owned prescriptions.
In our system, patient representation relies on a patient’s
role contract address without on-chain storage of a personally
identifying information.
5) PRESCRIBER ROLE CONTRACT

2) CONCRETE FACTORY CONTRACT

There are multiple concrete factory contracts (CFC) in our
system that create role contracts on behalf of the global
registry (GRC). Each concrete factory creates a specific
type of contract, inheriting functionality from one of the
four standard interfaces in our system (prescription, patient,
prescriber, or pharmacy). When coupled with the abstract
factory pattern via the GRC, these new CFCs create alternate implementations of role contracts despite the immutable
nature of blockchain smart contracts.
One alternate implementation might be a prescription for a
medication with a consumption limit. Such a contract could
prevent over-prescribing by tracking a prescription’s quantity
over a patient’s lifetime. Another example is a special contract for tracking controlled substances. Smart contracts could
convene with on-chain oracle services [19] or integrate with
existing prescription drug monitoring programs. Solutions
VOLUME 10, 2022

Prescriber role contracts represent unique prescribers within
VigilRx. Each prescriber contract has a list of patient contract
addresses under their care, as well as a mapping of prescription contract addresses for each patient. Each prescriber
contract includes a national provider identifier (NPI) from the
National Plan and Provider Enumeration System (NPPES)
database. Referencing this database allows the fetching of relevant data about the prescriber such as contact info, medical
specialty, and licensing status [20].
Prescriber role contracts are the main vehicle by which
new prescription contracts enter the VigilRx system. This
process begins with a prescriber generating a new prescription contract using the necessary prescription data and the
patient’s role contract address. The patient’s role contract then
receives the prescription contract address. If the prescriber
has permission to write prescriptions for the patient, then
the patient contract adds the new prescription address to an
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internal list. Otherwise, the process fails and any changes to
the blockchain are reverted.
Prescribers have special privileges over any prescriptions
they originate in this way. They may modify the number of
fills at any time and make use of filling/refilling flags to
facilitate patient care as needed.

to ensure the security of any personally identifying data.
Included with this information is the public key of the stakeholder and additional details such as the National Provider
Identifier (NPI) of the stakeholder if they are a prescriber or
pharmacist.

6) PHARMACY ROLE CONTRACT

Pharmacy role contracts represent pharmacies within the
VigilRx system. Like the prescriber role contract, all pharmacy contracts have a list of patient contract addresses and a
mapping of the prescription contracts for each patient. Each
prescriber contract also includes an NPI.
Pharmacy role contracts are the primary means by which
patients can get their prescriptions filled. To initiate that
process, the patient must first give the pharmacy permission
on one or more of their prescription contracts. The patient
can then initiate a fill on one of their prescriptions, changing
the fill flag. The change of this flag alerts the pharmacy to
start filling the prescription. Once the patient receives the
medication, the pharmacy interacts with the contract again
to confirm the removal of one fill and reset the flag.
If a fill request occurs and the prescription is out of fills,
then the pharmacy can set the prescription’s refill flag. The
change in this flag alerts the prescriber to review the prescription for refilling. If the prescriber approves the refill the
pharmacy can then continue the rest of the filling process.
D. SYSTEM ACTIONS

The following sections demonstrate the architecture of
VigilRx by showing how our system operates during the
writing and filling of prescriptions. We provide diagrams for
clarity, laying out the involvement of our smart contracts during the five primary actions within our system: role contract
creation, permissioning, prescribing, filling, and refilling.
We discuss these transactions in terms of the stakeholders for
the sake of clarity but it should be understood that actions
occur through role contracts and not the stakeholders directly.
See Table 1 for a breakdown of system actions available to
stakeholders.
TABLE 1. Actions available to each stakeholder.

1) ROLE CONTRACT CREATION

In order to create a new role contract, a stakeholder must send
a request and any necessary information to the administrator of the global registry contract (GRC). This information
transfer uses the Transport Layer Security (TLS) protocol
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FIGURE 2. Role contract creation in VigilRx.

Contract creation takes place on-chain via the GRC
through use of the abstract factory pattern. The administrator
transmits the stakeholder’s public key and any other necessary information to the GRC, along with a key referencing the GRC’s mapping of concrete factory contract (CFC)
addresses.
The GRC uses the key-specified CFC to create a new role
contract on the blockchain and assigns contract ownership
to the provided public key. The CFC returns the address of
this newly created contract to the GRC, where it is registered
according to its role. The original requester then receives the
newly created role contract address. Any personally identifying information necessary to establish the stakeholder’s
identity at the administrative level is never placed on-chain.
2) PERMISSIONING ACTION

VigilRx is patient-centric, meaning all access to prescription information originates with the patient. We achieve this
through a permissioning process that is started on-chain using
the patient’s role and prescription contracts. The remainder of
the process is completed off-chain using key encapsulation
and exchange.
There are two cases in which a patient may need to permission a healthcare provider. The first case occurs when
a patient wishes to allow a prescriber to write prescriptions
for them. The second occurs when a patient wishes to give a
pharmacist permission to fill their prescriptions.
In the first case the prescriber is permissioned via the
patient’s role contract. To begin this process, the patient
provides the role contract address of the desired provider to
their own role contract. The patient’s role contract confers
with the global registry contract and verifies whether the provided address belongs to a valid prescriber registered within
the system. This step prevents the accidental or malicious
entering of an invalid address. Once validated, this address is
VOLUME 10, 2022
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FIGURE 4. Prescribing action in VigilRx.

FIGURE 3. Permissioning in VigilRx.

added to a permissioned parties mapping within the patient’s
role contract and the process is complete.
The process to permission a pharmacy begins similarly.
The patient provides the address of a pharmacist role contract which is then validated through the GRC. However, the
contents of the patient’s prescription contracts are encrypted
in order to ensure privacy (see section IV-D3). Decryption of
the prescription contract’s contents requires the distribution
of a symmetric key associated with the prescription (S).
Generation of this key occurs during the prescribing process
(see IV-D3) and the patient stores it locally.
In order to remain selective, the distribution process must
target the intended recipient. We achieve this targeting by
encapsulating S using the target’s public key, via asymmetric
Elgamal encryption as follows:
Let (α1 , β1 ) = (S.h1r1 mod p, gr11 mod p) be the Elgamal
ciphertext encrypting secret key S using the public key h1 =
gx1 of provider P1 , where g1 is the generator of group G
whose order is a large p.
The patient performs the following:
r2
1) Produces ciphertext (α2 , β2 ) = (S.hr2
2 mod p, g2 mod p)
x2
encrypting S with public key h2 = g2 of provider P2 .
2) Uses Zero Knowledge Proof to prove that:
a) The key S obtained by decrypting (α1 , β1 ) with
x1 is the same key encrypted in (α2 , β2 ) : α2 =
α1 .β1−x1 .hr2
2 mod p, and
b) The secret key corresponding to (h1 , g1 ) is x1 , and
c) The randomness used to generate (α2 , β2 ) is r2 .
Once S encapsulation and the zero-knowledge proof (ZKP)
generation occurs, a database receives and stores both of
these. The intended party can then retrieve the encapsulated
key, decrypt it using their own secret key, and access the
contents of the patient’s prescription contract.

confirm that this process is complete the prescriber checks
the patient’s role contract to validate their address, ensuring its presence within the patient’s permission mapping.
Once permissioning confirmation occurs, the prescriber generates a symmetric key (S) that encrypts sensitive prescription
information, such as the national drug code (NDC) of the
medication and quantity being prescribed. This encryption is
necessary to ensure HIPAA compliance and ensure patient
control of future data access via the selective distribution of
this key.
Next, the prescriber encapsulates the symmetric key using
the public address of the patient through Elgamal encryption
and generates a zero knowledge proof (see section IV-D2).
Both are then committed to a database for future retrieval by
the patient.
This process could potentially occur on-chain rather than
using a public database. For the purposes of our implementation, on-chain key exchange proved infeasible due to specific
limitations with the Ethereum blockchain. Moving this process on-chain could be a fruitful area for future work.
After storing the encapsulated key, the prescriber assembles the prescription, encrypting the NDC and quantity
using S. The prescriber then commits the encrypted data
and the patient’s role contract address to the prescriber role
contract.
The role contract creates a new prescription contract
on-chain using this encrypted data and assigns ownership
of the prescription to the patient using their role contract
address. This process calls an additional function on the
patient’s role contract directly, adding the address of the
newly minted prescription contract to the patient’s listing. This ensures the preservation of the prescription contract address throughout the creation process and prevents
manipulation.
At this point, the patient can retrieve the encapsulated
key and decrypt the prescription’s contents. This gives them
access to their data and allows them to distribute access to
future care providers or pharmacies.

3) PRESCRIBING ACTION

Writing a new prescription in the VigilRx system first
requires the patient to permission the prescriber to issue
prescriptions on their behalf (see section IV-D2). In order to
VOLUME 10, 2022

4) FILLING ACTION

Filling begins with the patient permissioning the pharmacist
on one of their prescription contracts (see section IV-D2).
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The pharmacy verifies this permissioning and adds the
patient’s prescription contract to the listing on their pharmacy
role contract. The patient may then initiate a fill request by
accessing the prescription contract. This sets the prescription’s fill flag which notifies the pharmacy that the prescription requires filling. A listing of the patient’s prescription
contracts allows for the easy monitoring of these fill flag via
the publisher-subscriber pattern.
After notification, the pharmacy can then physically prepare the prescription. When the patient arrives to pick up
the prescription, the pharmacy turns over the medication and
then completes the fill on the prescription contract. The fill
flag resets, and the transaction is complete. Only the patient
can initiate this two-stage process and only the pharmacy
can complete it. This approach prevents either party from
requesting more than the correct share of fills and other
malicious behavior.

FIGURE 6. Prescription refill action in VigilRx.

laws like the General Data Protection Regulation an inherent
challenge which our system does not try to address. VigilRx
also does not solve issues concerning identity verification,
assuming an administrative compliance with current standards at the system’s entry point. VigilRx does not directly
attempt to address issues such as over-prescription, prescription errors, or filling errors that might originate from care
providers, however it does have potential uses in tracking
them.
B. ETHEREUM AND ENCRYPTION

FIGURE 5. Prescription fill action in VigilRx.

5) REFILLING ACTION

Refilling adjusts the number of fills available on a prescription contract. The prescription prescriber can directly modify
the number of refills at any time by calling the appropriate
prescription contract function.
A different process occurs when a patient requests a fill
with insufficient fills remaining. In this case, the pharmacist
can request a refill from the prescriber. The prescription contract’s refill flag is set, prompting the prescriber for approval.
The prescriber then has the choice to authorize more fills or
deny the request.
V. DISCUSSION
A. BLOCKCHAIN LIMITATIONS

VigilRx has certain limitations. Blockchain’s status as an
immutable ledger makes removing data in accordance with
25982

The encryption of on-chain personal health information is
a necessary part of the VigilRx system. Our use of a public and permissionless blockchain makes the encryption of
on-chain data vital in complying with HIPAA. One major
limitation with Ethereum is its maximum data size of 256 bits.
Given that the minimum key size for ElGamal encryption is
1024 bits, exchanging keys on-chain is not possible without
high-overhead workarounds.
However, we designed our system with the intention of
being feasible on any blockchain capable of running smart
contracts. Using a different blockchain may make it possible
to accomplish key exchange entirely on-chain and enhance
the decentralized nature of our system.
C. GDPR COMPLIANCE

The U.S. could potentially implement new legislation following the model of the European Union’s General Data Protection Regulation (GDPR) [30]. GDPR includes the ‘‘right to
be forgotten,’’ meaning the right to have stored personally
identifying information erased upon request.
While we see our system as taking the steps necessary to be
compliant with HIPAA, the immutable nature of blockchain
and our key-distribution scheme makes it difficult to comply
with the right to be forgotten. Truong et al. [17] proposed a
personal data management platform to address GDPR compliance. Integrating this platform into the VigilRx design may
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provide a sufficient solution to make our system compliant
with GDPR.
VI. EXPERIMENTAL EVALUATION
A. IMPLEMENTATION

We implemented our proposed system for the purposes of
testing scalability and efficiency. Most of our implementation focused on dapp development. However, we also built
a Django-based implementation of the VigilRx web app to
interface with our dapp as a proof-of-concept. Our basic
web app implementation allows non-technical stakeholders
to create role-based accounts for interacting with the VigilRx
dapp.
Within the dapp, we built the global registry contract,
prescription contract, and three role contracts proposed in our
solution. We implemented these contracts in the Solidity programming language and included functionalities for all major
prescription-related actions. We used the Python version of
the Web3 library to build an object-oriented and comprehensive bridge between the smart contracts and our off-chain
applications. We designed the bridge to interact with a local
Ganache blockchain where deployment of our dapp occurred
during each experiment. The bridge also connects our web
app to the dapp.
Using the bridge, we created a testing suite that allows for
simulation comparable to a real-world environment. In each
simulation cycle, stakeholders perform their relevant prescription actions. Patients select and permission random
providers (prescribers and pharmacies), prescribers create
new prescriptions for their patients, and pharmacists fill prescriptions every cycle. Each stakeholder completes all their
available actions in each cycle, although prescription creation
must occur in the first cycle before some actions can be
performed.

We specified a ratio of 60% patients, 30% prescribers, and
10% pharmacies. This distribution approximates the real-life
3-to-1 ratio between doctors and licensed pharmacists in the
United States, while still ensuring enough contracts for each
role at low volumes [25], [27].
We used static values for all contract generation that
occurred during our experiments. We populated NPI and
NDC values with 5555555555. This number represents an
average NPI or NDC value as both are 10-digit numbers.
We populated prescription quantity, fill count, and refill count
with the value 5. We chose 5 because it is a reasonable representation of single-digit numbers and ensures prescriptions
require refilling in all our experiments.
Under these conditions, we evaluated the VigilRx system
regarding scalability and efficiency. We allowed our simulation to run for 10 cycles in each experiment, increasing the
number of stakeholders in each experiment. In each cycle, all
stakeholders performed the actions relevant to their category
at the same time. This number of cycles was chosen because
it allowed us to conduct multiple tests within a reasonable
amount of time, given our computing resources.
The distribution of actions performed by stakeholders in
our experiments reflects our decision to use static values for
the fill and refill variables. As shown in Table 2, the refilling
action occurred the most as it is also the most common action
in the real-world.
TABLE 2. Distribution of actions by category.

B. TESTING ENVIRONMENT

The system used for our experiments contains an Intel R
TM
Core i5-7400 processor, 16 gigabytes of DDR4 memory,
and a Kingston A400 solid state drive, running the Ubuntu
20.04 operating system. During experimentation, we used
Ganache version 6.12.2 on this machine.
Ganache allows for the specification of environment settings. We use the Muir Glacier fork of Ethereum, which is
the newest version available through Ganache at the time
of writing. We use Ganache’s default gas limit of 6,721,975
units and no artificial delay in mining time. For any given
experiment, we initiated Ganache with accounts equal to
the number of stakeholders, plus one to represent the global
registry contract. Accounts were each initialized with the
Ganache default balance of 100 ether. We also set Ganache’s
keepAliveTimeout to 10,000 to decrease the likelihood of
connection timeouts during testing.
C. SIMULATION SETUP

Our testing suite design allowed us to define the distribution of different stakeholder role within the simulation.
VOLUME 10, 2022

The full source code for our smart contract and simulator
implementation is available here.1
D. SCALABILITY

We determined our system’s scalability by measuring its runtime with an increasingly large number of stakeholders. The
first test simulated 250 stakeholders and each subsequent test
increased this number by 250, up to 2,500 stakeholders. The
total runtimes and gas usage for each category of prescription
actions were recorded.
Fig. 7 shows the runtime for each test, with the number
of stakeholders on the x-axis and runtime in minutes on
the y-axis. Additionally, each prescription action category
appears individually in a stacked format. The total cost of
running the system with increasingly more stakeholders is
shown in Fig. 8. The x-axis contains the number of stakeholders during each test and the y-axis shows the Ethereum
gas usage (in millions).
1 https://github.com/vigilrxteam/VigilRx
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Fig. 9 displays the average runtime for each category
of prescription actions. The x-axis contains the number of
stakeholders in each test; the y-axis is the average runtime in
milliseconds. Fig. 10 shows the average quantity of gas used
(in thousands) during each test. The x-axis is the same as in
previous charts, with the y-axis representing Ethereum gas in
the thousands of units.

FIGURE 7. Scalability in relation to runtime.

We observed that VigilRx is scalable regarding runtime,
given its linear increase with the number of stakeholders in
the system. Fig. 7 shows this general linear trend, although
minor deviations are present. It is likely these deviations
occurred due to increased Ganache connection timeouts when
it initialized with many accounts. Support of this theory
lies in the higher deviations occurring at 2,250 and 2,500
accounts. At these levels, Ganache timeouts increased in
frequency. It follows that the deviations reflect the abilities of
the Ganache testing environment and not the VigilRx system
itself.

FIGURE 9. Efficiency in relation to runtime.

FIGURE 10. Efficiency in relation to gas usage.

FIGURE 8. Scalability in relation to gas usage.

Testing shows VigilRx’s near-perfect scalability regarding
gas usage, as seen in Fig. 8. The linear increase of gas usage
with number of stakeholders is obvious. The computation
required for each prescription action does not change at scale
and determines gas usage, thus the linear increase. It follows
that gas usage is scalable in the same manner.
E. EFFICIENCY

We tested the efficiency of VigilRx as part of our experimental evaluation. Measurement of the average Ethereum gas use
for each prescription action shows the system’s per action
cost. This data was produced in the same simulation used for
determining scalability, allowing cross-reference between the
system’s efficiency and scalability. Efficiency tests focused
on the average runtime and average gas usage for each type
of prescription action.
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Testing shows the efficiency of the VigilRx system in
regard to runtime and gas usage. Most actions in the system
require little overhead with average gas usage per action
falling under 90,000. One category is notably more expensive
than the others: prescribe actions. These actions include the
creation of new prescription contracts making the category’s
higher overhead expected (see Fig. 9). Prescription contract
deployment has a high upfront gas cost, but subsequent prescription actions are cheap as they simply call functions on
the newly deployed contract. This causes the overall average
gas usage to remain relatively low. All action categories have
near-constant average gas usage (shown in Fig. 10). Gas cost
represents the computation required for an on-chain action
and this computation does not change on a per-action basis
under our design, regardless of the number of stakeholders.
Some abnormalities occurred in VigilRx’s runtime during
our experimentation. Fig. 9 shows a general upward trend for
average runtime with variations especially prominent when
the number of stakeholders reaches 1,750 and 2,000. The
discussion on connection timeouts in section VI-D is one
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explanation for these deviations. General inconsistencies with
computing hardware or software are other possible causes.
VII. CONCLUSION

In this paper, we sought to design a blockchain system for
interoperable prescription management to give patients direct
authority over their data and removing the need for intermediaries like HISPs. The implementation of the VigilRx system
shows its ability to be deployed using smart contracts. Testing
shows our system remains both scalable and efficient as the
number of stakeholders increases. VigilRx promotes interoperability by removing existing differences in data formatting. The design removes the need for data duplication and
prevents siloing. Our system also promotes a patient-centric
design by requiring patient consent at every stage of the
prescribing process. Use of a global registry further protects
the patient by verifying the role of stakeholders throughout
the permissioning process. Lastly, VigilRx has the ability
to evolve. Use of software patterns allows future updates
to the system and establishes a thorough record of patient
care.
Technologies essential to our system are still under active
research including smart contracts, identity management,
and compliance with emerging regulation. Future research
in blockchain-based prescription management systems could
focus on topics like compliance with the General Data Protection Regulation (GDPR) [30]. Blockchain’s immutability makes complying with GDPR’s data removal provisions
inherently difficult. Truong et al. [17] have already done significant research in this area but future regulation may require
new solutions. Future work on the sharing of prescription data
with researchers could also prove fruitful. Other systems, like
MedRec [4], touch on this area of research but future work
could develop new methods of data sharing. Additionally,
future work could introduce drug compatibility checking to a
VigilRx-like prescription management system. Such a system
may benefit from use of the existing openFDA database to
determine compatibility, perhaps informed by the patient’s
on-chain history of care.
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